|
HS Code |
664312 |
| Product Name | Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid |
| Cas Number | 1420478-68-5 |
| Molecular Formula | C15H20FNO4 |
| Molecular Weight | 297.32 |
| Appearance | White to off-white solid |
| Purity | ≥98% |
| Melting Point | 97-101°C |
| Solubility | Soluble in DMSO, methanol |
| Smiles | CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)F)C(=O)O |
| Chirality | S-enantiomer |
| Protecting Group | Boc (tert-butoxycarbonyl) |
| Storage Temperature | 2-8°C |
| Application | Pharmaceutical intermediate |
| Synonyms | Boc-L-3-Amino-4-(4-fluorophenyl)butyric acid |
As an accredited Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White HDPE bottle containing 5 grams of Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid, securely sealed with a tamper-evident cap. |
| Shipping | Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid is shipped in secure, sealed containers to preserve chemical integrity. Packaging complies with safety regulations for transit of laboratory chemicals. During shipping, temperature and moisture are controlled as necessary, minimizing degradation. Documentation accompanies all shipments to ensure traceability and regulatory compliance. Handle with appropriate protective measures upon receipt. |
| Storage | Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid should be stored in a tightly closed container, in a cool, dry, and well-ventilated area. Protect it from moisture and direct sunlight. Ideally, keep at 2–8°C (refrigerated) and avoid exposure to incompatible materials such as strong oxidizing agents. Ensure proper labeling and follow all safety protocols for handling chemicals. |
Applications of Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid in Industrial ManufacturingAs an established direct manufacturer, we supply Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid to leading industrial partners for critical synthesis in active pharmaceutical ingredients, advanced peptide R&D, specialty chemical intermediates, and life science molecule custom manufacturing. Below we detail the core downstream sectors, with an emphasis on regulatory compliance, industrial ratios, workflow integration, and the nature of end products delivered by our manufacturer-direct clientele. 1. Chiral Pharmaceutical Intermediate for Antidiabetic Drug SynthesisOriginating as a key chiral building block in sitagliptin phosphate and related DPP-4 inhibitor pharmaceuticals, this acid supports precise enantioselective coupling during API manufacturing. Our clients in regulated pharma sectors deploy this protected amino acid in commercial-scale amidation and deprotection stages, supporting compounds that meet strict regulatory consistency. Synthesizers follow pharmacopoeial monographs to guarantee absolute stereochemical purity and low residual by-products in the final API. We uphold tailored QC batch release protocols with full traceability for all B2B deliveries. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Protected Amino Acid for Peptide & Oligopeptide SynthesisWithin contract peptide manufacturing, downstream users rely on this Fmoc/BOC-protected amino acid to insert fluorinated side chains into synthetic oligopeptides, contributing to enhanced receptor binding and metabolic stability in novel therapeutics. It participates in solid-phase peptide synthesis (SPPS) or solution-phase chemistry, where protection strategies align with the full peptide sequence plan and must support GMP traceability and release for clinical or preclinical supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chiral Synthon in Targeted Oncology Small Molecule DevelopmentSpecialty pharma chemical developers specify this compound as a key intermediate in the production of next-generation kinase inhibitors and targeted cancer therapeutics, where the fluorophenyl side chain supports binding profile optimization. This material’s chemical purity and controlled optical rotation enable reliable scale-up synthesis, with in-process controls required from the first kilogram batch to regulatory pilot lots. The intermediate’s use must support downstream FDA, EMA, or PMDA submission processes for IND-enabling batches. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fluorinated Motif in CNS-Active Small Molecule Fine ChemicalsManufacturers of central nervous system (CNS) drug products select this acid to introduce a 4-fluorophenyl moiety, improving crossing of the blood-brain barrier and metabolic stability in lead CNS compounds. Production sites integrate this protected synthon into chain elongation or fragment coupling steps following validated SOPs, with batch release requiring full elemental analysis and impurity profiling. This material supports both reference batch creation and commercial launch scale-up for investigational CNS actives. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid in-house demands more than a sharp skill in organic synthesis. It takes dedication, carefully sourced starting materials, and years of hands-on refinement before scaling a process to meet the purity requirements the pharmaceutical industry expects. This compound, often requested for peptide coupling and intermediate steps in the creation of advanced drug candidates, arises from a controlled sequence of reactions. Workers in our facility monitor each batch with finely tuned analytical equipment, and nothing ships until HPLC and NMR results confirm that every specification has been met. No matter how many times a bench chemist produces this molecule, the challenge never fades: high-purity product, repeatable stereochemistry, consistent lot-to-lot performance.
Attention to detail sets a manufacturer’s product apart. Through direct production—never brokering or rebottling—our team manages each variable that influences quality, from the solvent grade used in the alkylation to the temperature control during Boc-protection. Our lot records show the tight tolerances we watch over. Reliable scale-up has come from troubleshooting each step, learning which filtration methods promote higher yield, and identifying the purification approaches that offer clean and quick isolation. This boots-on-the-floor experience matters. Slight shifts in process change the impurity profile or the recovery rate, so there’s no cutting corners. Batch after batch, chemists review the optical rotation and purity, confirming the stereoselectivity required in demanding synthetic routes. Supplying researchers with product that works the same way every time means we answer to our own reputation—something traders or distributors can’t claim because they don’t run reactors, isolate solids, or perform the analytical runs themselves.
This molecule supports a range of pharmaceutical research initiatives, especially where the design centers around constrained amino acid analogues. Medicinal chemists tell us that access to high-purity Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid matters most for lead optimization and structure-activity work. Experimental work often hinges on reliable side-chain protection that holds up under hydrogenation, as well as on the seamless removal of the Boc-group without residual impurities that can spoil downstream coupling. We make this product to meet those needs, never sacrificing on the elemental analysis or enantiomeric excess, because the labs working with our product are doing research that leads to the next wave of treatments.
We keep the specifications practical, focusing on achievable chiral purity, narrow melting range, and trace impurity levels based on what researchers in real-world projects demand. Each customer has deadlines and can’t wait an extra week because a shipment fails incoming QC; we’re acutely aware that hard deadlines in synthesis don’t pause for raw material issues. The salt form, solid state, and solvent content come directly from market requests. From early process design, our chemists measure how the compound behaves in solid form—whether it cakes, whether it picks up moisture, how quickly it dissolves in peptide coupling solvents. All this makes a difference for large-scale usage, especially as the product goes from grams in the lab to kilos in developing process chemistry routes.
Beyond R&D labs, process chemists rely on intermediates that handle upscaling gracefully. Our production process for Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid runs at safety standards suitable for scale, and our laboratory team continuously updates procedures to handle changes in environmental regulation and industrial best practices. Feedback loops from customers allow us to fine-tune crystallization and drying steps so product moves efficiently from synthesis to the next stage, helping process scale-up to proceed without unexpected issues. Over years, we’ve learned the value of keeping detailed process logs not just for internal audits, but also so that technology transfer to the customer’s facility is as seamless as possible. That experience allows us to answer technical questions quickly and with specifics—not vague generalities found on secondhand spec sheets.
This compound brings a distinct set of properties to synthetic and medicinal chemistry. The presence of a 4-fluorophenyl moiety means it behaves differently in coupling reactions than non-fluorinated analogues. We’ve observed, both in process development and in published literature, that properly managed fluorine positions can impact binding affinity and metabolic stability for peptide-based drug targets. The S-stereochemistry offers unique options for chiral center manipulation, and the Boc group remains one of the most reliable protections for amino functionality, balancing ease of deprotection with robust defense against side reactions. This combination leads chemists to choose our product over more generic alternatives, especially where cost and time for additional purification need to be minimized.
Manufacturing Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid throws up hurdles—each stage of the synthesis can introduce side products, and poor conditions quickly lower the isolated yield or the stereochemical purity. Years of in-house trial and error point to several pitfalls: impure starting 4-fluorobenzyl bromide, Boc anhydride that carries over acid impurities, loss of material during crystallization if the solvent isn’t just right. We run side-by-side trials when introducing a new source for any key reagent, because even a subtle shift in supply chain quality ripples through to the final product. Lab notes document every deviation, and we emphasize open communication in our team when something goes amiss. We keep a policy of sharing out-of-spec lots for technical review, not for sale, deepening collective experience and avoiding repeated mistakes. Our ultimate goal: a product traceable by batch history, not corporate copywriting.
Conversations with long-term customers shape our priorities in production. We hear quickly if a shipment doesn’t dissolve as well as previous lots, or if a trace impurity pops up in their NMR work. Sharing customer feedback at team meetings directly leads us to interrogate our own process, bringing new analytical standards online where gaps show up. Our scaleup team regularly tests the material in actual couplings with model peptides, seeking confirmation that everything from glass transition temperature to solubility in DMF passes muster. Wasted time debugging a sticky intermediate costs both our customer and our business. By narrowing in on these details, we offer not just product but ongoing technical support drawn from direct experience, not from a distant technical manual with answers that don’t match reality in the lab.
In-house oversight helps us keep the process in line with global quality standards, but we don’t stop at ticking boxes for USP or EP guidelines. Instead, we chart the impurity profile and revise it as we learn more from downstream processing challenges. For example, the appearance of specific low-level byproducts triggers an internal review—not just for regulatory compliance but for practical use in research. We improve purification steps where bottlenecks show, investing in rotary evaporation, lyophilization, or column chromatography that matches the required lot sizes. Each drum or pack leaving our dock comes with documentation checked fresh, not photocopied from prior lots. Years of batch records speak louder than certifications or third-party stamps.
We track the origin of every gram that enters the plant and link each batch of Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid to records of the raw materials and synthesis conditions used. Batch-to-batch consistency has built trust with customers running multi-step syntheses where a quality drop in a single intermediate sets a project back by weeks. The team understands just how important this reliability is for high-throughput screening and medicinal chemistry, where hundreds of analogues may be synthesized using the same intermediate. A failure in our supply could ripple out into costly delays or outcomes that don’t meet the end-goal. We refuse to risk that and use in-house quality checks to ensure confidence from project to project.
Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid does not simply stand as another protected amino acid. The distinct fluoro group alters the electronic characteristics, changing how the side-chain interacts in both small-molecule and peptide synthesis. Laboratories working on fluorine-containing leads know that the physical and chemical behavior is not interchangeable with non-fluorinated analogues. They see the difference in solubility, reactivity, and even long-term storage properties. Reliable batch synthesis further distinguishes our offering from traders picking up material spot from various low-cost sources. Our legacy stands on detailed technical support and years providing the same molecular signature every time. Researchers controlling every variable in their high-stakes experiments come back to us because they count on performance at every level, not just a spec sheet value.
A pharmaceutical discovery group might only need 10 grams for their feasibility run, but a process chemistry team could require kilograms as a kilogram intermediate. Because we cover both, we’ve learned how packaging, transportation, and documentation don’t just matter—they’re often decision points for our partners. Samples must reach their destination fast, in usable form, protected from exposure and moisture. We’ve invested in robust packing methods and reliable environmental monitoring along the route. Any deviation brings a technical team to check out root causes, reviewing everything from logistics to vendor-supplied secondary containers. Our partners have grown to trust that what arrives is what they planned for—and in the world of active intermediates, small margins count.
Running our own facility from start to finish means never substituting ingredients, and never passing down the quality risk chain. Our team has hands-on expertise in analytical chemistry and organic synthesis, not just on paper but at the plant each day. As processes evolve—sometimes due to regulation, sometimes to improve yield—each change passes a thorough internal review, logged with the outcomes at each stage. This means researchers looking for scalability or reproducibility access real support, not scripted answers. Knowing where and how the product was made makes the difference, especially in regulatory audits or in project troubleshooting mid-stream. No generic answers—just grounded, experience-driven solutions.
Across the years, the regulatory landscape for building block chemicals has tightened. Environmental requirements and scrutiny around fluorinated intermediates especially push manufacturers to update protocols and implement greener methods. We’ve invested in waste minimization, solvent recycling, safe handling, and process reviews so that environmental compliance keeps pace without sacrificing product quality. For every improvement, we run pilot batches to verify that the adjusted process delivers product at the same specification as before. Communication with customers about regulatory changes is transparent, because they rely on us for uninterrupted supply and updates that let their projects move forward on schedule. Experience has taught us never to delay hard conversations about sourcing or compliance; a surprise at the regulatory desk is never acceptable, so we staff a team dedicated to regulatory watch and product stewardship.
Our Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid often makes its way into routes for constrained peptides, non-natural amino acid derivatives, or beyond. Research teams depend on batch-to-batch consistency throughout long-term projects, as single lots may stretch to multiple years of work. In our experience, the best way we can support this is by maintaining documented lot reserves, running periodic stability analyses, and preserving technical support data for years. We hold back sample retains so that, if a downstream synthesis runs into a snag, we can dig back into the original batch and help troubleshoot with the same material used at the project’s start. Such continuity builds robust partnerships—and often, after trials with outside suppliers, chemists return to us seeking details only a maker can provide.
We run in-house development projects using our own Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid to validate new synthetic methods, and share findings with customers to shorten project timelines. Hands-on technical staff field questions about reactivity, optimal coupling reagents, or post-coupling purification based not on theory but on daily practice. Because we have our own glassware, purification gear, and analytical suites, every lesson learned improving our own yields passes straight to every new customer order. Teams working on time-critical projects know that if something unexpected happens, we pick up the phone and talk senior chemist to senior chemist, not through bureaucratic layers or delayed technical channels. That responsiveness supports not just immediate needs but long-term progress and builds trust that endures as complex projects unfold.
Cost-conscious purchasing is always important, yet labs using Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid for critical routes know the true price shows up in impurity handling, downstream rework, or lost hours. We’ve seen numerous projects where discount lots from secondary sources failed acceptance testing, causing entire synthesis campaigns to halt. Getting it right from the outset—through in-house quality, transparent records, and full technical backup—has saved more than just procurement budgets; it secures faster project timelines and fewer surprises. Value sits not in the lowest list price, but in the assurance that what is ordered is engineered for attention to every detail from synthesis to shipment.
Continuous improvement shapes the way we view production. Even as analytical tools and automation advance, experience remains core. Our team embraces both the time-tested and the innovative, seeking ways to adjust reaction routes for greener solvents, faster conversion, and higher overall yield without compromising the exacting standards that have built our legacy. Young scientists entering the field work shoulder-to-shoulder with experienced laboratory supervisors, all learning to check and double-check not only the chemistry but also the systems and records that guarantee a product’s journey from reactor to customer bench.
Supplying Boc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid as a manufacturer stands as both a technical and a personal commitment. End-users—from biotech startups to global pharmaceutical leaders—count on us for more than inventory. The foundation isn’t just about chemistry; it’s about the trust that every step in our factory is carried out by people who care about their craft, who see beyond single shipments, and who build their career on honest results. Our promise comes from every lesson learned on the bench and in the plant, echoed by customers who know that real reliability shows up in every packed box, every batch, and every word of advice shared along the way.